You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

spike glycoprotein

Showing 1 - 25 of 585
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mucosal Immunity in Terms of SARS-CoV-2 Antibodies in Saliva

Not yet recruiting
  • Covid19
  • Blood- and saliva tests
  • (no location specified)
Apr 12, 2021

COVID-19 Trial in New Taipei City (Covid19 Vaccination dose)

Recruiting
  • COVID-19
  • Covid19 Vaccination dose
  • New Taipei City, Taiwan
    TuCheng Hospital
Apr 24, 2023

COVID-19, SARS-CoV-2 Acute Respiratory Disease Trial in Hanoi (COVID-19 Vaccine HIPRA, Cominarty (Pfizer-BioNtech))

Active, not recruiting
  • COVID-19
  • SARS-CoV-2 Acute Respiratory Disease
  • COVID-19 Vaccine HIPRA
  • Cominarty (Pfizer-BioNtech)
  • Hanoi, Vietnam
    National Institute of Hygiene and Epidemiology
Aug 2, 2022

Coronavirus Infection, SARS-CoV 2 Trial in Seongnam-si, Seoul (biological, device, other)

Completed
  • Coronavirus Infection
  • SARS-CoV 2
  • INO-4800
  • +2 more
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
  • +1 more
Jul 14, 2022

Post Authorization Safety Study Moderna COVID-19 Primary Vaccine

Completed
  • COVID-19
  • Moderna COVID-19 Vaccine
  • Jakarta Pusat, Jakarta, Indonesia
  • +17 more
Aug 22, 2023

COVID-19 Trial in Lianyungang (batch 1 of Ad5-nCoV, batch 2 of Ad5-nCoV, batch 3 of Ad5-nCoV)

Completed
  • COVID-19
  • batch 1 of Ad5-nCoV
  • +2 more
  • Lianyungang, Jiangsu, China
    Guanyun Center for Disease Control and Prevention
Apr 5, 2022

Antibody Response to COVID19 Vaccination in Multiple Sclerosis

Completed
  • Multiple Sclerosis
  • Covid19
    • Livingston, New Jersey
      Saint Barnabas Medical Center
    Aug 16, 2022

    Coronavirus Trial in Wuhu (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Recombinant

    Active, not recruiting
    • Coronavirus
    • Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
    • Recombinant novel coronavirus protein vaccine (CHO cells)
    • Wuhu, Anhui, China
      Wannan Medical College Yijishan Hospital
    May 6, 2023

    COVID-19 Trial in Nanjing (Ad5-nCoV-IH, Ad5-nCoV-IM, CoronaVac)

    Active, not recruiting
    • COVID-19
    • Ad5-nCoV-IH
    • +2 more
    • Nanjing, Jiangsu, China
      Jiangsu Provincial Center for Diseases Control and Prevention
    Aug 12, 2022

    Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients

    Not yet recruiting
    • Covid-19 Pandemics
    • Tuberculosis
    • Pfizer-BioNTech COVID-19 vaccine
    • +2 more
    • Mae Sot, Tak, Thailand
      Shoklo Malaria Research Unit (SMRU)
    Oct 21, 2022

    COVID-19 Trial in Tashkent (Omicron-Delta Recombinant Novel Coronavirus Protein Vaccine (CHO cells), Recombinant Novel

    Recruiting
    • COVID-19
    • Omicron-Delta Recombinant Novel Coronavirus Protein Vaccine (CHO cells)
    • Recombinant Novel Coronavirus Protein Vaccine (CHO cells)
    • Tashkent, Uzbekistan
      Uzbekistan, Tashkent city, Said baraka street 10
    Nov 11, 2022

    Iron Deficiency Anemia Trial in Nairobi (dietary supplement, biological, other)

    Recruiting
    • Iron Deficiency Anemia
    • Iron supplementation
    • +4 more
    • Nairobi, Kenya
      Jomo Kenyatta University Of Agriculture And Technology
    Oct 30, 2023

    Covid19 Trial in United States (CVXGA1 low dose, CVXGA1 high dose)

    Recruiting
    • Covid19
    • CVXGA1 low dose
    • CVXGA1 high dose
    • Bardstown, Kentucky
    • +3 more
    Aug 16, 2022

    COVID-19, Vaccine Reaction, SARS CoV 2 Infection Trial in Bamako (Ad26.COV2.S, NVX-CoV2373)

    Not yet recruiting
    • COVID-19
    • +3 more
    • Ad26.COV2.S
    • NVX-CoV2373
    • Bamako, Mali
      CVD-MALI
    Jun 7, 2022

    COVID-19 Trial in Japan (Group A (AG0302-COVID19), Group A (Placebo), Group B (AG0302-COVID19))

    Completed
    • COVID-19
    • Group A (AG0302-COVID19)
    • +3 more
    • Narita, Chiba, Japan
    • +7 more
    Jun 7, 2022

    COVID-19, SARS-CoV-2 Trial in Indonesia, Mexico (SARS-CoV-2 mRNA Vaccine, Placebo)

    Recruiting
    • COVID-19
    • SARS-CoV-2
    • SARS-CoV-2 mRNA Vaccine
    • Placebo
    • Jakarta, Indonesia
    • +11 more
    Nov 10, 2021

    Certain Disorders Involving the Immune Mechanism Trial in Tours (Sampling, PCR (polymerase chain reaction) SARS-CoV-2)

    Not yet recruiting
    • Certain Disorders Involving the Immune Mechanism
    • Sampling
    • PCR (polymerase chain reaction) SARS-CoV-2
    • Tours, France
      CHRU de Tours
    Nov 17, 2023

    Cellular and Humoral Immunity to COVID-19 in Moscow Residents

    Recruiting
    • Covid19
    • Respiratory Viral Infection
    • SARS-CoV-2 specific IgM and IgG detection
    • +2 more
    • Moscow, Russian Federation
      Clinical City Hospital named after I.V. Davydovsky of Moscow Dep
    May 21, 2021

    Coronavirus Infection Trial in Lexington, Kansas City, Philadelphia (INO-4800, CELLECTRA® 2000)

    Completed
    • Coronavirus Infection
    • Lexington, Kentucky
    • +2 more
    Apr 13, 2022

    COVID-19 Trial in United States (drug, biological, other)

    Active, not recruiting
    • COVID-19
    • Birmingham, Alabama
    • +21 more
    Feb 2, 2023

    COVID-19, SARS-CoV-2 Acute Respiratory Disease Trial in Spain (COVID-19 Vaccine HIPRA, Cominarty (Pfizer-BioNtech))

    Recruiting
    • COVID-19
    • SARS-CoV-2 Acute Respiratory Disease
    • COVID-19 Vaccine HIPRA
    • Cominarty (Pfizer-BioNtech)
    • Badalona, Barcelona, Spain
    • +9 more
    Sep 27, 2022

    COVID-19 Trial in Bizerte, Ariana, Tunis (CoronaVac/CoronaVac, CoronaVac/BNT162b2)

    Completed
    • COVID-19
    • CoronaVac/CoronaVac
    • CoronaVac/BNT162b2
    • Bizerte, Mateur, Tunisia
    • +4 more
    Jan 4, 2023

    COVID-19 Infection, COVID-19 VACCINE Trial in Thailand (AstraZeneca ChAdOx1 AZD1222 vaccine (AZ) full dose, Pfizer/BioNTech

    Completed
    • COVID-19 Infection
    • COVID-19 VACCINE
    • AstraZeneca ChAdOx1 AZD1222 vaccine (AZ) full dose
    • +3 more
    • Bangkok Noi, Bangkok, Thailand
    • +6 more
    Jul 3, 2022

    Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Trial in Abu Dhabi (NVX-CoV2373 with Matrix-M adjuvant Injection,

    Recruiting
    • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
    • NVX-CoV2373 with Matrix-M adjuvant Injection
    • BBIBP-CorV vaccine
    • Abu Dhabi, United Arab Emirates
    • +1 more
    Mar 24, 2022

    COVID-19 Vaccination Trial in Hong Kong (BNT162b2, CoronaVac)

    Active, not recruiting
    • COVID-19 Vaccination
    • BNT162b2
    • CoronaVac
    • Hong Kong, Hong Kong
      The University of Hong Kong
    Feb 8, 2022